Research Study

Treating Anxiety in Parkinson's Disease With a Multi-Strain Probiotic (TAP)
Principal Investigator 
Silke Cresswell

Overview

Body Locations and Systems 
Parkinson's Disease
Disorders and Conditions 
Anxiety
ClinicalTrials.gov# 
NCT03968133
Status 
Recruiting
Study Start/End 
Jan 1, 2021
Locations 
UBC Hospital
Name/Title 
Petra Uzelman, Clinical Research Nurse
Phone 
604-827-0576
Email Address 
petra.uzelman@ubc.ca
Purpose of Study 

The purpose of this study is to evaluate the use of an oral multi-strain probiotic in the treatment of anxiety in individuals with Parkinson's Disease. 

Eligibility 

Visit ClinicalTrials.gov for more information. 

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.